Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
20.67B | 26.40B | 16.46B | 15.64B | 37.60B | Gross Profit |
17.06B | 20.68B | 12.47B | 11.63B | 28.19B | EBIT |
557.00M | -2.99B | -8.22B | -9.79B | -256.00M | EBITDA |
797.00M | -1.58B | -2.87B | -5.36B | 944.00M | Net Income Common Stockholders |
901.00M | 13.31B | -4.81B | -9.33B | 727.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
12.34B | 14.36B | 3.56B | 4.76B | 26.60B | Total Assets |
31.57B | 32.10B | 59.92B | 61.87B | 62.89B | Total Debt |
38.00M | 38.00M | 31.89B | 37.20B | 29.44B | Net Debt |
-12.30B | -14.32B | 28.33B | 32.44B | 2.84B | Total Liabilities |
11.69B | 13.16B | 43.83B | 50.97B | 2.01B | Stockholders Equity |
19.88B | 18.94B | 16.09B | 10.90B | 20.13B |
Cash Flow | Free Cash Flow | |||
-2.09B | -503.00M | -5.16B | -5.26B | -268.00M | Operating Cash Flow |
-1.62B | 81.00M | -4.10B | -3.98B | 1.09B | Investing Cash Flow |
-478.00M | 53.42B | -1.13B | -1.32B | -1.59B | Financing Cash Flow |
-36.00M | -42.70B | 4.03B | 7.48B | -1.51B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥105.36B | 11.98 | 0.43% | 14.07% | -0.42% | ||
74 Outperform | ¥1.29T | 28.74 | 1.73% | 24.10% | 11.27% | ||
67 Neutral | ¥32.54B | 4.50 | ― | 3.76% | -15.66% | ||
67 Neutral | $75.82B | 12.14 | 2.70% | 7.65% | 6.79% | ||
61 Neutral | $6.69B | 11.69 | 3.01% | 3.94% | 2.60% | -21.51% | |
60 Neutral | ¥15.15B | 7.27 | 0.50% | 3.48% | -89.81% | ||
58 Neutral | $383.54B | 16.03 | 15.24% | 1.58% | 32.68% | 86.73% |